As usual Baz, you make no mistake as to the path you're on
Sometimes, some investors are better to stay quiet....
but you did say it...
"What a shame CYP haven't got a manufacturing problem or do they? If they could manufacture large quantities, better and cheaper than Lonza wouldn't it be wise for them to strike a deal with MSB ?"
What a shame you guys can't even tell the difference in basic MSC production/source/trials to date.
as for this one....
"it is rather obvious that with CYP's speedy progress any test of IP will be decades away."
is just plain laughable given CYP is Phase 2 ready and Japan can be marketed and sold after just P2 (maybe 30 patients only for competing GvHD product)....and how long it's taken for MSB to reach Phase 3. I'd say 15 years + for 1 product is rather slow don't you.
I'd counter 6.5 years for Phase 2 ready and 1 partnership is ahead of ol Gen 1 MSB.
so why do you think "decades" away when it could be only 2 years?
- Forums
- ASX - By Stock
- MSB
- MSB Trading - 2020
MSB Trading - 2020, page-12854
-
- There are more pages in this discussion • 10,307 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 73626 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | 1.485 |
5 | 59100 | 1.480 |
4 | 60253 | 1.475 |
3 | 35489 | 1.470 |
1 | 34513 | 1.465 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 73626 | 3 |
1.505 | 29500 | 2 |
1.510 | 41232 | 6 |
1.515 | 123153 | 3 |
1.520 | 81763 | 5 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
MSB (ASX) Chart |